Ruti Aga: The Price of a Forged Prescription, The Grave of a Career

A runner's career can be ended not by a banned substance but by a forged piece of paper. This sounds strange, but it is exactly what happened to Ethiopian marathoner Ruti Aga. Last week, the Athletics Integrity Unit (AIU) handed her a six-year ban. This ban was not for taking a banned substance, but for forging a prescription with the help of a family member. What makes this case even more serious is that it was not a minor mistake, but a calculated conspiracy to tamper with evidence. The most tragic part is that this six-year ban is effectively the end of her career. At 32, a six-year ban means she will be 38 when she returns. Given the depth of Ethiopian marathon running, that age effectively eliminates any hope of a comeback at the elite level. To understand the root of the case, we must go back to a half marathon in China in March. Aga won that race. A doping test conducted after the victory found methylprednisolone in her sample. Here, a technical point must be understood, which most media reports have presented incorrectly. Methylprednisolone is indeed a steroid, but it is not the anabolic steroid known for building muscle. It is a glucocorticoid, which falls under category S9 of WADA's Prohibited List. This means it is prohibited only during competition, and only via injection, oral, or rectal routes. This difference is the key to the entire case. Receiving a methylprednisolone injection for knee pain is common practice for distance runners. If Aga had genuine records of this treatment, she could have defended herself by showing the treatment happened out of competition, or she could have had time to apply for a Therapeutic Use Exemption (TUE). But she did not do that. Instead, she chose a path that proved suicidal for her career. The AIU investigation revealed that the clinic that supposedly issued the prescription did not exist at all. The 'doctor' who issued it was a family member of Aga's, with no medical registration. And when this came to light, he claimed he had used 'an old prescription pad from a former workplace.' This was a statement that made the case worse. The clinic that supposedly issued the prescription explicitly denied that the pad belonged to them. The AIU found two separate violations in this case. First, the presence of a prohibited substance during competition, which resulted in a two-year ban. Second, tampering, i.e., creating fake documents and making misleading statements during the investigation, which resulted in an additional four-year ban. Together, they form a six-year ban. The arithmetic is straightforward, but the implications are profound. The panel signaled that it rejected Aga's 'no significant fault' defense. In the absence of genuine medical records, that defense was unlikely to work anyway. Looking at the entire case, one thing becomes clear: this is not just an athlete's mistake, but a deep failure of the medical governance system in East African road running. Aga did not have a credentialed team doctor. Her medical care was the responsibility of an informal network, which proved instrumental in ending her career rather than saving it. This is not an isolated case. The AIU has several cases of East African runners where an initial substance violation was compounded by an attempt to tamper with fabricated or altered documents. Now the question arises: is this just an individual failure, or a systemic flaw that has been ignored? The answer is the latter. Marathon runners suffering from knee injuries have incentives to mask pain because their income depends on their performance. Glucocorticoids are the cheapest and easiest tool for this. When the surrounding medical system is informal, mistakes are inevitable. As for Aga's career, her legacy is now divided into two parts. On one side is the 2026 Tokyo Marathon title and a record of three runner-up finishes at World Marathon Majors, which proves she was a genuine elite marathoner. On the other side, this ban makes her commercially radioactive. In a sport where sponsorship is already scarce, there is no place for an athlete with a doping record. This entire case also offers a larger lesson, one relevant to Indian athletics as well. We often think doping only means taking banned drugs, but the real danger lies in the system around it. When an athlete works without credentialed medical support, when they do not receive proper guidance for their injury, and when their income is tied to their performance, they make decisions that end their career. Aga's case is proof that sometimes the biggest risk is not the banned substance itself, but the attempt to hide the truth about that substance.